By affecting appetite, reward pathways, and behavior, these medications may open new possibilities for treating obesity, addiction, and compulsive disorders
BMJ Glob Health
Biochimie 86 , 839848 (2004)
Klinic offers four FDA-approved medications for weight management: Zepbound (injectable tirzepatide, once weekly), Wegovy (injectable semaglutide, once weekly), Oral Wegovy (semaglutide tablet, once daily), and Foundayo (orforglipron tablet, once daily)
NOX family members normally regulate cellular physiological functions, but under abnormal circumstances contribute to the pathogenesis of cell/tissue damage associated with infections and vascular disorders (Panday et al., 2015)